A

Tianming Pharmaceutical Group

bout  Us

Founded in 2010, Shandong Tianming Pharmaceutical is a state-level high and new tech enterprise that is engaged in the innovation, manufacture and sales for genieric drugs. The registered capital of Shandong Tianming Pharmaceutical Group Co., Ltd reach 40 million RMB. There are three manufacture bases: Shandong Sihuan Pharmaceutical Co., Ltd, Guangxi Tianming Pharmaceutical Co., Ltd and Jining Tianming Pharmaceutical Co., Ltd. Shandong Tianming Pharmaceutical Technology Co., Ltd and Nanjing Tianming Pharmaceutical Technology Co., Ltd are two R&D centers of Shandong Tianming Pharmaceutical Group Co., Ltd. There are also sales companies in India and Bangladesh. Our cooperative manufacturers and companies are from all over the world.

The fields related to our company’s products include antibiotic APIs and related intermediates (Cefmenoxime, Cefazedone, Cefapirin, etc.), anti-cardiovascular APIs and related intermediates (LCZ696, AHU-377 (heMicalciuM salt), etc.), anti-diabetic APIs and related intermediates (Alogliptin, Linagliptin, Empagliflozin, etc.), anti-tumor APIs and related intermediates(Ibrutinib, Baricitinib, Tofacitinib, etc.), anti-aging APIs and related intermediates(PQQ) and anti-viral APIs and related intermediates(Baloxavir marboxil, Nafamostat mesylate, Cytidine, 2',3'-O-(1-methylethylidene)-, 5'-(2-methylpropanoate), etc.)

  • The fields related to our company’s products include manufacturing pharmaceutical intermediates(anti-viral< Baricitinib , 3'-O-(1-methylethylidene)-, 5'-(2-methylpropanoate), Baloxavir marboxil, Tenofovir alafenamide hemifumarate >、anti-diabetic< Alogliptin benzoate, Trelagliptin succinate, Linagliptin, Empagliflozin, Dapagliflozin>、anti-tumor< Ibrutinib, Osimertinib,     Brigatinib >、anti-cardiovascular< Sacubatrava valsartan sodium > and health care products< PQQ>). Hazardous chemicals are not included.

    SHANDONG TIANMING PHARMACEUTICAL GROUP CO., LTD
    SHANDONG SIHUAN PHARMACEUTICAL CO., LTD
    GUANGXI TIANMING PHARMACEUTICAL CO., LTD

COMPANY ENVIRONMENT

COMPANY ENVIRONMENT

Plant Environment

Shandong Tianming Pharmaceutical Group currently has three major production plants, two in Shandong Province and one in Guangxi Zhuang Autonomous Region.

Office Area

Clean and bright office environment, with office, reception, meeting, training and other functions

Production Facilities

Each factory area has independent synthesis production workshop and pilot workshop. The total annual production capacity is 1,200 tons of raw materials and intermediates.

Supporting Facilities

The company's complete supporting facilities can meet the full production needs of all workshops in each factory area.